Jonathan McNeill, Chief Business Officer: Dyne Therapeutics DYN Sell · Filed 24/05/17

Trade details

Type: Insider sale
Amount: $64,267.8
Shares · price: 2,279 sh · $28.20 a share
Held after: 137,129 sh
Stock: Dyne Therapeutics DYN
Person: Jonathan McNeillChief Business Officer
Trade date: 24/05/16
Filed: 24/05/17
Days to filing: 1 days

Sold 1.6% of holdings

Share of holding sold: 1.6%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/16~24/06/15

Jonathan McNeill's recent trades

Jonathan McNeillPresident and COO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$75.8K
4,415 sh
$75.8K
Filed 09/17
Traded 09/18
Jonathan McNeillPresident and COO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$15.1K
804 sh
$15.1K
Filed 09/16
Traded 09/16
Jonathan McNeillPresident and COO
Sell10b5-1 planCrescent Biopharma
Sell10b5-1 plan
Crescent Biopharma
CBIO
$369.7K
20,549 sh
$369.7K
Filed 06/23
Traded 06/22
Jonathan McNeillChief Business Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$108K
2,400 sh
$108K
Filed 24/08/20
Traded 24/08/19
Jonathan McNeillChief Business Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$14K
305 sh
$14K
Filed 24/08/20
Traded 24/08/19